160 related articles for article (PubMed ID: 17675819)
1. [Natural history of inflammatory bowel disease].
Matsui T
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1172-82. PubMed ID: 17675819
[No Abstract] [Full Text] [Related]
2. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor therapies. Foreword.
Magro F
BioDrugs; 2010 Dec; 24 Suppl 1():1-2. PubMed ID: 21175227
[No Abstract] [Full Text] [Related]
3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
Tiemi J; Komati S; Sdepanian VL
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
[TBL] [Abstract][Full Text] [Related]
5. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
Wittig BM; Zeitz M
Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
[No Abstract] [Full Text] [Related]
6. Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.
Regadas FS; Pinto RA; Murad-Regadas SM; Canedo JA; Leal M; Nogueras JJ; Wexner SD
Colorectal Dis; 2011 May; 13(5):555-60. PubMed ID: 20070344
[TBL] [Abstract][Full Text] [Related]
7. [Changing treatment of inflammatory bowel diseases].
Karvonen AL; Matikainen M; Turunen U
Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
[No Abstract] [Full Text] [Related]
8. Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Burakoff R
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S202-3. PubMed ID: 18816760
[No Abstract] [Full Text] [Related]
9. [Inflammatory bowel disease: should all patients be premedicated when infliximab is administered to reduce infusion reactions and/or immunogenicity?].
Ginard D; Mariño Z
Gastroenterol Hepatol; 2008 Oct; 31(8):542-3. PubMed ID: 18928758
[No Abstract] [Full Text] [Related]
10. [Current status of treatment of inflammatory bowel disease].
Rodríguez-Moranta F; Soriano-Izquierdo A; Guardiola J
Cir Esp; 2007 Nov; 82(5):254-9. PubMed ID: 18021623
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs to treat Crohn's disease.
van Assche G
Expert Opin Emerg Drugs; 2007 Mar; 12(1):49-59. PubMed ID: 17355213
[TBL] [Abstract][Full Text] [Related]
12. [Biologicals first-line in chronic inflammatory bowel disease? Yes].
Stallmach A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1788. PubMed ID: 21882134
[No Abstract] [Full Text] [Related]
13. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Lichtenstein GR; Abreu MT; Cohen R; Tremaine W;
Gastroenterology; 2006 Mar; 130(3):935-9. PubMed ID: 16530531
[No Abstract] [Full Text] [Related]
14. Crohn disease or intestinal fistulising tuberculosis? Diagnosis difficulties in a case treated with infliximab and corticosteroids.
Cazacu S; Vere CC; Comănescu V; Dumitrescu C; Enache SD; Ciurea T
Rom J Morphol Embryol; 2009; 50(2):263-8. PubMed ID: 19434321
[TBL] [Abstract][Full Text] [Related]
15. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
Lichtenstein GR; Sbreu MT; Cohen R; Tremaine W
Rev Gastroenterol Mex; 2006; 71(3):351-401. PubMed ID: 17140062
[No Abstract] [Full Text] [Related]
16. Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: a community practice experience.
Shen H; Lipka S; Katz S
J Crohns Colitis; 2014 Aug; 8(8):898-9. PubMed ID: 24434182
[No Abstract] [Full Text] [Related]
17. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Lichtenstein GR; Abreu MT; Cohen R; Tremaine W;
Gastroenterology; 2006 Mar; 130(3):940-87. PubMed ID: 16530532
[No Abstract] [Full Text] [Related]
18. [TNF-alpha blocking therapy in chronic inflammatory bowel disease].
Molnár T
Orv Hetil; 2009 Sep; 150(38):1773-9. PubMed ID: 19740722
[TBL] [Abstract][Full Text] [Related]
19. Infliximab safety profile and long-term applicability in inflammatory bowel disease: clinical experiences from the eastern side of Europe.
Molnár T; Farkas K; Nagy F; Szepes Z; Wittmann T
Aliment Pharmacol Ther; 2010 May; 31(10):1152-3. PubMed ID: 20518754
[No Abstract] [Full Text] [Related]
20. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
